Amorfix achieves target sensitivity with its Alzheimer's disease diagnostic test(06/26/2008) Amorfix Life Sciences announced that its diagnostic test for the presence of aggregated Abeta in Alzheimer's disease is ready to be applied to patient samples. The company has adapted its test to specifically detect aggregated Abeta protein ...
Amorfix detects scrapie prions in blood from asymptomatic sheep(05/05/2008) Amorfix Life Sciences Ltd. announced the detection of endogenous prions in the blood plasma of asymptomatic scrapie infected sheep. The company had previously reported detecting symptomatic sheep which was a requirement for testing of human vCJD in ...
Amorfix Life Sciences appoints Aziz Mekouar as a member of Board of Directors(01/08/2008) Amorfix Life Sciences announced the appointment of Aziz Mekouar to the company's Board of Directors. Mr. Mekouar is currently the Ambassador of Morocco to the United States and participated in the negotiation of the Morocco/United States free trade ...
Amorfix Life Sciences discovers common link between ALS and Alzheimer's Disease(11/29/2007) Amorfix Life Sciences announced the discovery of misfolded superoxide dismutase 1 (SOD1) protein in the brains of people with Alzheimer's Disease. This breakthrough result suggests that SOD1 is a common link between the two brain-wasting diseases, ...
Amorfix Life Sciences' test detects scrapie prions in bllod ofg scrapie-infected sheep(10/29/2007) Amorfix Life Sciences announced the results from the testing of a blinded panel of blood samples from scrapie infected sheep. Amorfix correctly identified 18 out of 20 individual sheep blood samples in a blinded panel provided by an independent ...
Amorfix achieves first milestone in therapeutic ALS partnership with Biogen Idec(07/25/2007) Amorfix Life Sciences announced that it has received notice from Biogen Idec that they will be exercising the first milestone investment under the August 2006 research and investment agreement. The milestone investment allows Biogen Idec to retain ...
Amorfix receives ISO13485 certification(06/19/2007) Amorfix Life Sciences announced that it has achieved ISO13485:2003 certification for its in vitro diagnostic EP-vCJDTM test for detection of aggregated misfolded proteins in variant Creutzfeldt-Jacob Disease (vCJD)."This achievement is a significant ...
Amorfix recruits ALS leader, Joseph Beckman, Ph.D. to join Scientific Advisory Board(06/12/2007) Amorfix Life Sciences announced that Joseph Beckman, Ph.D., will join the Company's Scientific Advisory Board. Dr. Beckman is an expert in Amyotrophic Lateral Sclerosis (ALS) disease and the role of superoxide dismutase-1 (SOD1) in this disease. Dr. ...
Top